Boyle James M
SEC CIK 2061052 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MDLN | Medline Inc. | CEO, Dir | 29.4K | — | — | 3 | 2025-12-16 | 2026-06-15 |
Most active insiders at MDLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CG Subsidiary Holdings L.L.C. | 10% | — | $1.63B |
| 2 | HFCP X (Parallel-A), L.P. | 10% | — | $1.23B |
| 3 | BX Mozart ML-2 Holdco L.P. | 10% | — | $1.22B |
| 4 | Hellman & Friedman Capital Partners X (Parallel), L.P. | 10% | — | $1.16B |
| 5 | Mozart Aggregator II UNLV Holdco L.P. | 10% | — | $1.13B |
| 6 | Blackstone Group Management L.L.C. | 10% | — | $1.13B |
| 7 | CP Circle ML-5 Holdco, L.P. | 10% | — | $1.07B |
| 8 | CPEP Circle Holdings L.P. | 10% | — | $1.07B |
| 9 | TC Group Cayman Investment Holdings Sub L.P. | 10% | — | $1.07B |
| 10 | GIC Special Investments Pte Ltd | 10% | $365.00M | $289.50M |
| 28 | Boyle James M | CEO, Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-17 16:44 | 2026-06-15 | MDLN | Medline Inc. | Boyle James M | CEO, Dir | F - Tax | $36.61 | -2,370 | 29.4K | -7% | -$86.8K | |
| DM | 2026-03-06 | 2025-12-16+ | MDLN | Medline Inc. | Boyle James M | CEO, Dir | A - Grant | $0.00 | +56.1K | 31.7K | New | $0 |
| DI | 2026-03-06 | 2025-12-16 | MDLN | Medline Inc. | Boyle James M | CEO, Dir | A - Grant | — | +514.9K | 514.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations